1. RNA nanoparticles carry negative charges, which reduce nonspecific binding to negatively charged cell membrane;
2. RNA nanoparticles through controlled synthesis have defined structure and stoichiometry;
3. Multi-Valency (combined therapy, targeting and detection);
4. Targeted delivery ensures high therapeutic efficacy while minimizing non-specific side effects and toxicity.